Colorcon, a provider of film coating systems and excipients for the pharmaceutical and nutritional industries, has launched OptiClenz High Performance Cleaning.
Colorcon Ventures, the corporate venture fund of Colorcon Inc., has invested in Apprentice.io, a provider of Intelligent Manufacturing Execution Systems (MES) designed specifically for the life sciences industry.
HARLEYSVILLE, Pa., Jan. 13, 2022 /PRNewswire/ -- Colorcon Ventures, the corporate venture fund of Colorcon Inc., has invested in VeriSIM Life, a San Francisco-based startup with a digital bio-simulation platform that accelerates drug development and reduces animal testing.
The new Acryl-Eze II coatings line increases the pH range offered for delayed-release oral solid-dosage drugs and other items.
The company’s SoteriaRx platform offers on-dose technology and detection services for authenticating a broad range of medications.
Colorcon, a developer and supplier of film coating systems and excipients, has launched SoteriaRx, a new platform of on-dose technologies and detection services for the authentication of medications, designed to protect patients and uphold brand integrity.
Colorcon, a developer of advanced coating systems, modified-release technologies, and functional excipients for pharmaceuticals, announced on Sept. 17, 2019 the establishment of a $50 million venture fund to invest in startup companies developing technologies to advance manufacturing, supply chain, and delivery of pharmaceutical products and services.
Colorcon and TruTag Technologies, Inc. have executed a development agreement to enable on-dose verification technology for tablets by combining TruTag’s silica-based microtag authentication technology with Colorcon’s expertise in film coating systems, modified release technologies and specialty excipients.
Colorcon has created a coating system it says makes swallowing tablets easier, fulfilling patient compliance demands in recent regulatory guidance.